Seres Therapeutics Files 8-K on Financials
Ticker: MCRB · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
TL;DR
SERES filed an 8-K on Aug 6, 2025, updating financials & operations. Check it out.
AI Summary
Seres Therapeutics, Inc. filed an 8-K on August 6, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 101 Cambridgepark Drive, Cambridge, MA.
Why It Matters
This 8-K filing provides an update on Seres Therapeutics' financial condition and operational results, which is crucial information for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not appear to contain any significant new risks or material adverse events.
Key Players & Entities
- Seres Therapeutics, Inc. (company) — Registrant
- August 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 101 Cambridgepark Drive, Cambridge, MA 02140 (address) — Principal executive offices
- 001-37465 (identifier) — Commission File Number
- 27-4326290 (identifier) — IRS Employer Identification No.
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are not provided in the header.
When was the earliest event reported in this filing?
The earliest event reported was on August 6, 2025.
What is Seres Therapeutics, Inc.'s state of incorporation?
Seres Therapeutics, Inc. is incorporated in Delaware.
Where are Seres Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 101 Cambridgepark Drive, Cambridge, MA 02140.
What is the Commission File Number for Seres Therapeutics, Inc.?
The Commission File Number is 001-37465.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding Seres Therapeutics, Inc. (MCRB).